Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 28 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
Tripathy D, Tolaney SM, Seidman AD, Anders CK, Ibrahim N, Rugo HS, Twelves C, Diéras V, Müller V, Du Y, Currie SL, Hoch U, Tagliaferri M, Hannah AL, Cortés J, ATTAIN Investigators
JAMA Oncol, 8(7):1047-1052, 01 Jul 2022
Cited by: 5 articles | PMID: 35552364 | PMCID: PMC9100460
Add to export list Free full text in Europe PMC
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
Wai Siu DH, O'Neill RS, Harris CA, Wang J, Ardolino L, Downton T, Tong M, Hong JH, Chin V, Clingan PR, Aghmesheh M, Soudy H
Immunotherapy, 14(7):511-520, 24 Mar 2022
Cited by: 5 articles | PMID: 35321560
Add to export list
Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers.
Siu DHW, Ali A, Tjokrowidjaja A, De Silva M, Lee J, Clingan PR, Aghmesheh M, Brungs D, Mapagu C, Goldstein D, O'Neill S, Liauw WS, Sjoquist KM, Thomas D, Pavlakis N, Clarke SJ, Diakos C, Chantrill LA
Asia Pac J Clin Oncol, 18(6):660-668, 30 Jan 2022
Cited by: 0 articles | PMID: 35098672
Add to export list
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment.
Clingan PR, Ackland SP, Brungs D, de Souza P, Aghmesheh M, Garg MB, Garg MB, Ranson RD, Parker S, Jokela R, Ranson M
Asia Pac J Clin Oncol, 15(3):151-157, 06 Mar 2019
Cited by: 0 articles | PMID: 30843362
Add to export list
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.
Cohn AL, Yoshino T, Heinemann V, Obermannova R, Bodoky G, Prausová J, Garcia-Carbonero R, Ciuleanu T, Garcia-Alfonso P, Portnoy DC, Van Cutsem E, Yamazaki K, Clingan PR, Polikoff J, Lonardi S, O'Brien LM, Gao L, Yang L, Ferry D, [...] Tabernero J
Cancer Chemother Pharmacol, 80(3):599-608, 25 Jul 2017
Cited by: 12 articles | PMID: 28744667 | PMCID: PMC5573752
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Chiorean EG, Von Hoff DD, Reni M, Arena FP, Infante JR, Bathini VG, Wood TE, Mainwaring PN, Muldoon RT, Clingan PR, Kunzmann V, Ramanathan RK, Tabernero J, Goldstein D, McGovern D, Lu B, Ko A
Ann Oncol, 27(4):654-660, 22 Jan 2016
Cited by: 60 articles | PMID: 26802160 | PMCID: PMC4803454
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Describing Patterns of Care in Pancreatic Cancer: A Population-Based Study.
Burmeister EA, OʼConnell DL, Beesley VL, Goldstein D, Gooden HM, Janda M, Jordan SJ, Merrett ND, Payne ME, Wyld D, Neale RE, Pancreatic Cancer Patterns of Care Study Group
Pancreas, 44(8):1259-1265, 01 Nov 2015
Cited by: 14 articles | PMID: 26262591
Add to export list
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F, RAISE Study Investigators
Lancet Oncol, 16(5):499-508, 12 Apr 2015
Cited by: 482 articles | PMID: 25877855
Add to export list
Comparative effectiveness of 5-fluorouracil with and without oxaliplatin in the treatment of colorectal cancer in clinical practice.
Healey E, Stillfried GE, Eckermann S, Dawber JP, Clingan PR, Ranson M
Anticancer Res, 33(3):1053-1060, 01 Mar 2013
Cited by: 7 articles | PMID: 23482781
Add to export list
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
Kirkwood JM, Gonzalez R, Reintgen D, Clingan PR, McWilliams RR, de Alwis DP, Zimmermann A, Brown MP, Ilaria RL, Millward MJ
Cancer, 117(20):4732-4739, 31 Mar 2011
Cited by: 17 articles | PMID: 21456002
Add to export list
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK, Vine KL, Locke JM, Chrisp JS, Bremner JB, Clingan PR, Ranson M
Anticancer Drugs, 22(1):24-34, 01 Jan 2011
Cited by: 5 articles | PMID: 20881836
Add to export list
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.
Kefford RF, Clingan PR, Brady B, Ballmer A, Morganti A, Hersey P
Mol Cancer, 9:69, 30 Mar 2010
Cited by: 31 articles | PMID: 20350333 | PMCID: PMC2856553
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.
Gibbs P, Clingan PR, Ganju V, Strickland AH, Wong SS, Tebbutt NC, Underhill CR, Fox RM, Clavant SP, Leung J, Pho M, Brown TJ
Cancer Chemother Pharmacol, 67(1):153-163, 24 Mar 2010
Cited by: 26 articles | PMID: 20333384
Add to export list
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Locke JM, Stutchbury TK, Vine KL, Gamble AB, Clingan PR, Bremner JB, Ranson M
Anticancer Drugs, 20(9):822-831, 01 Oct 2009
Cited by: 3 articles | PMID: 19606016
Add to export list
Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy.
Gruenberger T, Zhao J, King J, Chung T, Clingan PR, Morris DL
Cancer, 94(6):1753-1759, 01 Mar 2002
Cited by: 4 articles | PMID: 11920538
Add to export list
Radiologically placed hepatic artery catheter allows selection of patients with high-volume liver metastases for regional chemotherapy.
Zhao J, Clingan PR, Glenn D, Morris DL
Australas Radiol, 42(3):204-206, 01 Aug 1998
Cited by: 2 articles | PMID: 9727242
Add to export list
Previous intravenous chemotherapy does not alter response rate or survival time of patients with hepatic metastases from colorectal cancer treated by hepatic artery chemotherapy.
Morris DL, Zhao J, Clingan PR
Aust N Z J Surg, 67(11):796-797, 01 Nov 1997
Cited by: 3 articles | PMID: 9396998
Add to export list
Major upper gastrointestinal haemorrhage associated with hepatic arterial chemoperfusion.
Ross WB, Morris DL, Clingan PR
Aust N Z J Surg, 66(12):816-819, 01 Dec 1996
Cited by: 1 article | PMID: 8996061
Add to export list
Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy.
Preketes AP, Caplehorn JR, King J, Clingan PR, Ross WB, Morris DL
World J Surg, 19(5):768-771, 01 Sep 1995
Cited by: 27 articles | PMID: 7571679
Add to export list
An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting.
Olver IN, Craft PS, Clingan PR, Kearsley JH, Planner RS, van Hazel GA, Bell DR, Adena MR, Hall BE, Pearson LL
Med J Aust, 164(6):337-340, 01 Mar 1996
Cited by: 1 article | PMID: 8606657
Add to export list
Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases.
Dasappa V, Ross WB, King J, King DW, Clingan PR, Morris DL
Int J Colorectal Dis, 11(1):38-41, 01 Jan 1996
Cited by: 1 article | PMID: 8919340
Add to export list
A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer.
Links M, Clingan PR, Phadke K, O'Baugh J, Legge J, Adams WJ, Ross WB, Morris DL
Eur J Surg Oncol, 21(5):523-525, 01 Oct 1995
Cited by: 12 articles | PMID: 7589598
Add to export list
Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion.
Morris DL, Horton MD, Dilley AV, Warlters A, Clingan PR
Gut, 34(9):1156-1157, 01 Sep 1993
Cited by: 38 articles | PMID: 8406144 | PMCID: PMC1375444
Add to export list Free full text in Europe PMC
CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival.
Preketes AP, King J, Caplehorn JR, Clingan PR, Ross WB, Morris DL
Aust N Z J Surg, 64(9):612-614, 01 Sep 1994
Cited by: 19 articles | PMID: 8085975
Add to export list
Hepatic artery cytotoxic perfusion therapy after cryotherapy: a single patient control trial?
Horton MD, Walters A, Dilley AV, Clingan PR, Morris DL
Med J Aust, 155(11-12):849, 01 Dec 1991
Cited by: 1 article | PMID: 1745189
Add to export list

1-25 of 28 results

1 2

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding